v3.26.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2026
Stockholders' Equity  
Schedule of changes in Stockholders' Equity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

Accumulated

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

​

Common

​

Common

​

Additional

​

Other

​

​

​

​

Total

​

​

Stock

​

Stock Par

​

Paid-In

​

Comprehensive

​

Accumulated

​

Stockholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Value

  ​ ​ ​

Capital

  ​ ​ ​

Income

  ​ ​ ​

Deficit

  ​ ​ ​

Equity

​

​

(In thousands, except share amounts)

Consolidated balance at December 31, 2025

 

66,549,442

​

$

67

​

$

2,337,453

​

$

3,626

​

$

(1,813,981)

​

$

527,165

Shares issued under stock option and employee stock purchase plans

 

19,529

​

​

—

​

​

327

​

​

—

​

​

—

​

​

327

Stock-based compensation

 

—

​

​

—

​

​

8,523

​

​

—

​

​

—

​

​

8,523

Unrealized loss on marketable securities

 

—

​

​

—

​

​

—

​

​

(1,104)

​

​

—

​

​

(1,104)

Net loss

 

—

​

​

—

​

​

—

​

​

—

​

​

(78,685)

​

​

(78,685)

Consolidated balance at March 31, 2026

 

66,568,971

​

$

67

​

$

2,346,303

​

$

2,522

​

$

(1,892,666)

​

$

456,226

Shares issued under stock option and employee stock purchase plans

​

34,452

​

​

—

​

​

825

​

​

—

​

​

—

​

​

825

Shares issued in underwritten offering, net

​

11,896,750

​

​

12

​

​

323,820

​

​

—

​

​

—

​

​

323,832

Stock-based compensation

​

—

​

​

—

​

​

8,408

​

​

—

​

​

—

​

​

8,408

Unrealized loss on marketable securities

​

—

​

​

—

​

​

—

​

​

(1,224)

​

​

—

​

​

(1,224)

Net loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(73,503)

​

​

(73,503)

Consolidated balance at June 30, 2026

​

78,500,173

​

$

79

​

$

2,679,356

​

$

1,298

​

$

(1,966,169)

​

$

714,564

Shares issued under stock option and employee stock purchase plans

​

34,265

​

​

—

​

​

1,115

​

​

—

​

​

—

​

​

1,115

Stock-based compensation

​

—

​

​

—

​

​

10,974

​

​

—

​

​

—

​

​

10,974

Unrealized loss on marketable securities

​

—

​

​

—

​

​

—

​

​

(1,627)

​

​

—

​

​

(1,627)

Net loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(75,557)

​

​

(75,557)

Consolidated balance at September 30, 2026

​

78,534,438

​

$

79

​

$

2,691,445

​

$

(329)

​

$

(2,041,726)

​

$

649,469

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Accumulated

​

​

​

​

​

​

​

​

Common

​

Common

​

Additional

​

Other

​

​

​

​

Total

​

​

Stock

​

Stock Par

​

Paid-In

​

Comprehensive

​

Accumulated

​

Stockholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Value

  ​ ​ ​

Capital

  ​ ​ ​

 Income

  ​ ​ ​

Deficit

  ​ ​ ​

 Equity

​

​

(In thousands, except share amounts)

Consolidated balance at December 31, 2024

 

66,374,549

 

$

66

 

$

2,298,849

 

$

3,314

 

$

(1,555,224)

 

$

747,005

Shares issued under stock option and employee stock purchase plans

 

9,642

 

 

—

 

 

202

 

 

—

 

 

—

 

 

202

Stock-based compensation

 

—

 

 

—

 

 

9,316

 

 

—

 

 

—

 

 

9,316

Unrealized gain on marketable securities

 

—

 

 

—

 

 

—

 

 

254

 

 

—

 

 

254

Net loss

 

—

 

 

—

 

 

—

 

 

—

 

 

(53,796)

​

 

(53,796)

Consolidated balance at March 31, 2025

 

66,384,191

​

$

66

​

$

2,308,367

​

$

3,568

​

$

(1,609,020)

​

$

702,981

Shares issued under stock option and employee stock purchase plans

​

10,050

​

​

—

​

​

63

​

​

—

​

​

—

​

​

63

Stock-based compensation

​

—

​

​

—

​

​

9,191

​

​

—

​

​

—

​

​

9,191

Unrealized loss on marketable securities

​

—

​

​

—

​

​

—

​

​

(229)

​

​

—

​

​

(229)

Net loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(56,600)

​

​

(56,600)

Consolidated balance at June 30, 2025

​

66,394,241

​

$

66

​

$

2,317,621

​

$

3,339

​

$

(1,665,620)

​

$

655,406

Shares issued under stock option and employee stock purchase plans

​

52,605

​

​

—

​

​

774

​

​

—

​

​

—

​

​

774

Stock-based compensation

​

—

​

​

—

​

​

8,801

​

​

—

​

​

—

​

​

8,801

Unrealized gain on marketable securities

​

—

​

​

—

​

​

—

​

​

426

​

​

—

​

​

426

Net loss

​

—

​

​

—

​

​

—

​

​

—

​

​

(67,044)

​

​

(67,044)

Consolidated balance at September 30, 2025

​

66,446,846

​

$

66

​

$

2,327,196

​

$

3,765

​

$

(1,732,664)

​

$

598,363

​